Ensign Peak Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-3,681
| Closed | -$419K | – | 1807 |
|
2022
Q4 | $419K | Sell |
3,681
-103,758
| -97% | -$11.8M | ﹤0.01% | 1656 |
|
2022
Q3 | $6.65M | Sell |
107,439
-25,563
| -19% | -$1.58M | 0.02% | 462 |
|
2022
Q2 | $10.6M | Buy |
133,002
+45,038
| +51% | +$3.59M | 0.03% | 375 |
|
2022
Q1 | $9.26M | Sell |
87,964
-18,649
| -17% | -$1.96M | 0.02% | 437 |
|
2021
Q4 | $11.5M | Buy |
106,613
+74,407
| +231% | +$8.02M | 0.02% | 433 |
|
2021
Q3 | $3.53M | Buy |
32,206
+24,997
| +347% | +$2.74M | 0.01% | 803 |
|
2021
Q2 | $675K | Hold |
7,209
| – | – | ﹤0.01% | 1540 |
|
2021
Q1 | $664K | Sell |
7,209
-120,358
| -94% | -$11.1M | ﹤0.01% | 1543 |
|
2020
Q4 | $9.33M | Sell |
127,567
-7,359
| -5% | -$538K | 0.02% | 431 |
|
2020
Q3 | $10.5M | Sell |
134,926
-10,558
| -7% | -$820K | 0.03% | 437 |
|
2020
Q2 | $8.09M | Sell |
145,484
-29,140
| -17% | -$1.62M | 0.02% | 474 |
|
2020
Q1 | $5.17M | Buy |
174,624
+60,264
| +53% | +$1.78M | 0.02% | 503 |
|
2019
Q4 | $4.14M | Buy |
+114,360
| New | +$4.14M | 0.01% | 704 |
|